论文信息 - Management of Cytokine Release Syndrome in AML Patients Treated with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Molecule for T-Cell Redirected Therapy - 字舞流文

Management of Cytokine Release Syndrome in AML Patients Treated with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Molecule for T-Cell Redirected Therapy

C. Viero | J. Dipersio | J. Wigginton | S. Paolini | F. Ravandi | H. Lelièvre | N. Vey | B. Löwenberg | D. Rizzieri | K. Jacobs | Shengyan Hong | F. Ciceri | M. Arellano | G. Huls | G. Uy | M. Carrabba | J. Davidson-Moncada | K. Ying | K. Sweet | J. Muth | Jichao Sun | M. Rettig | M. Topp | J. Godwin | J. Baughman | M. Foster